Background: Previous studies have found interaction between lower extremity artery disease (LEAD) and systemic vascular effects.
Results:
Out of 120 patients, 39 had mild LEAD (mean ABI 0.81 ± 0.07) and 81 had advanced LEAD (mean ABI 0.57 ± 0.11). Symptomatic LEAD was significantly more frequent in patients with advanced LEAD (59% vs. 93.8%, p < 0.001). No significant differences were found in demographic and laboratory findings (age, gender, body mass index, history of diabetes, smoking, hypertension and hyperlipidemia, fasting blood glucose, serum creatinine, total cholesterol, triglycerides, HDL and LDL cholesterol). Three arterial stiffness parameters: ß index, PWV-ß and Ep, were significantly higher in advanced forms of LEAD (ß index median: 8. 
